Cite
Economic impact of treatments for controlling symptoms associated with rhinitis: An evaluation of Narivent® vs standard therapy
MLA
Valerio Damiani, et al. Economic Impact of Treatments for Controlling Symptoms Associated with Rhinitis: An Evaluation of Narivent® vs Standard Therapy. Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6ce30c22627852f5ad39a1100f5b3895&authtype=sso&custid=ns315887.
APA
Valerio Damiani, Antonella Silvia Scire, Claudio Viti, Dario Gregori, Angelo Camaioni, Dilyana Vicheva, Giulia Schillani, & Giada Morpurgo. (2012). Economic impact of treatments for controlling symptoms associated with rhinitis: An evaluation of Narivent® vs standard therapy.
Chicago
Valerio Damiani, Antonella Silvia Scire, Claudio Viti, Dario Gregori, Angelo Camaioni, Dilyana Vicheva, Giulia Schillani, and Giada Morpurgo. 2012. “Economic Impact of Treatments for Controlling Symptoms Associated with Rhinitis: An Evaluation of Narivent® vs Standard Therapy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6ce30c22627852f5ad39a1100f5b3895&authtype=sso&custid=ns315887.